MedPath

Effect of cinnamon supplementation in patients with Polycystic Ovary Syndrome

Not Applicable
Conditions
Polycystic Ovarian Syndrome.
Polycystic Ovarian Syndrome
Registration Number
IRCT201508173664N14
Lead Sponsor
Tabriz University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
84
Inclusion Criteria

Female:20-38 years old, 25=BMI>40; At least two standard measurement of amenorrhea or oligomenorrhea; Clinical or laboratory hyperandrogenism and polycystic ovary on ultrasonography . Exclusion criteria: Thyroid disorders; Hyperprolactinemia, Cushing's syndrome; Liver and kidney diseases; Cardiovascular disease; High blood pressure and diabetes; Pregnant and lactation women; Consumers of anti-obesity and blood lipid-lowering drugs; Anticoagulants and glucocorticoids drugs; Loss wieght diet; smokers; Very active and athletes; Allergic to cinnamon; Seizure and epilepsy disorders ; Cerebrovascular disorders; Individuals undergoing infertility treatments and beta-blockers.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Metabolic status. Timepoint: Begining and end of the intervention. Method of measurement: Serum kit.
Secondary Outcome Measures
NameTimeMethod
Serum level of adiponectin. Timepoint: Beginig anf end of the intervention. Method of measurement: Serum kit.
© Copyright 2025. All Rights Reserved by MedPath